Regulation of adenylate cyclase-coupled beta adrenergic receptor binding sites by beta adrenergic catecholamines in vitro.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000526:Alprenolol / Q000031:analogs & derivatives / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology*; D004361:Drug Tolerance; D004837:Epinephrine / Q000494:pharmacology; D004912:Erythrocytes / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011458:Prostaglandins E / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000187:drug effects*
D002395:Catecholamines; D011458:Prostaglandins E; D011941:Receptors, Adrenergic; D000526:Alprenolol; D011433:Propranolol; D000262:Adenylyl Cyclases; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine